The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
" Initial market cap of £32.8m V current £47.7m "
You are making a mistake in suggesting it was an "initial" MCAP...
It was a fund raise that was carried out on the London market .... and it was only the fund raise issue of new shares that was priced at 1.47p
These were previously..and remain...listed on the Australian stock market...where retail investors have previously been tapped for fund raising ..and probably got exhausted having suffered the same fate....
They chose to raise in London because they knew there was an untapped set of retail investors who they could get to buy their 1.475p shares off them at highly inflated prices...
The BOD here don't really care how long the trials and administration processes takes ..they get paid well every month
...and have good relations with the City who will do them a fund raise and make sure they make their money out of it too, in exchange ...
More change of a lower intraday low.
I wonder what tomorrow will bring ? News perhaps ?
CountingCards. Insightful post and agree that while torturous, time will tell. Im no different from a lot of retail in that id like a return perhaps too quickly. This sector moves slower than most and its one for the bottom drawer for me. No way I would sell out at a loss as id rather be in for the ride. You analysis of MCP is promising and helps to illustrate progress. Cheers.
Just for the record:
Debuted on 09.02.2021, with the market cap of around £32.8m, and had 2.229bn shares at 1.475p.
Current market cap is based today’s price of about 1.8p and with 2.682bn shares around £47.7m.
During the year it recorded a high of 9.25p, which at one point shot the market cap to around £206m.
The shares are mostly driven by retail investors, who have a tendency to hold short term, and there has been no real record of significant holders. Therefore the price action reflects exactly what you would expect from a retail driven stock. Its volatile! Its slow torture! Its predicted to never recover!
As results are due soon, that could all change, and recently the trading has shown signs that the stock has been accumulated (see Mid Dec to Mid Jan) and that retail are being driven to the edge of desperation. A few said you cannot gain any evidence that charts tell anything. It certainly cannot predict price movement going forward, but what it can evidently show is the pattern of price behaviour, which right now is going lower. It’s being driven lower because retail sell in droves more than long term buyers accumulate. The fact that is has been nothing but a straight line down for six months is more evidence that this has been retail to blame.
Initial market cap of £32.8m V current £47.7m with results on the way? Retail are again making the classic continuous mistakes. No proof results will be good or bad right but right now retail are in the driving seat and they are driving it over the edge of a cliff and convincing themselves it’s all bad.
Capital raised, contracts signed though incestuous in some cases, and in an industry likely to explode upwards, it’s going to be interesting.
NOTE to retail: Biggest ever mistake. Invested in VMP in 2010, price kept dropping for 4 years, invested all the way from 3p down to 0.04p! held 5m or 1% of the company, losses were life changing, the negativity immense, the calls to get out from others rising each day. Robbers! Thiefs! Roll on 2014 just wanted my money back, sold for £30000 when it bagged multiples, and walked away with profits. Thank God I was out. Roll on 2022 VMP is REAT and my holding would have been £175000! Now who is laughing?
You can ilsten to soothsayers the ones who don’t research properly, they are your best friends and they will keep you poor and convince you from the 10 minutes they have held to get out while you can.
LOL the HotCopper board is a good read. They just love Roby and his mates.
I found it after I'd invested and thought it was sour grapes but I know better now... but there are some good informative posts on there for new investors and those of us who have to hold in the hope of breaking even.
But be warned though, they won't inspire much if any confidence.
Same place as the Canadian application
" Further SPC orders for ArtemiCTM from MGC Pharma are set to continue following the grant of the Certificate of Free Trade in Germany and the EU in September 2021"
so..where are they then ?...they are behind the schedule set....should have had another quarterly order by now....
I doubt much will change until the Malta facility gets up and running, and we find out some specifics about what it wlil be doing/making. I doubt its herbal pill to cure covid will do much but happy to be proven wrong. I just keep my fingers crossed they come up with some good cannabis based products whether CBD or THC based, and if Roby Zomer is involved in all these other companies, that he isnt spread too thin (which its pretty obvious he must be if hes active in all of them).
Still, got a relatively big stake (for me), so hoping everything works out eventually.
Ha!! Spank.the.monkey. That's usually how I roll.
You can expect to receive some transformational news imminently, I've just sold out.
Agreed. The scilence is deafening. Always "jam tomorrow" thats if there is an update at all. Obviously if there is nothing to update then we hear nothing. Im concerned that this may transpire as lack of general progress on any front or notable sales. Would be great to be proven wrong here.
Could be that. Or, could equally be an advanced warning that was shot down?
That person probably got in and out at the wrong time and probably just bitter
I seem to recall an Australian investor warning us about MXC on this board when they first listed in the UK but I ignored him thinking it was just sour grapes.....perhaps he was right. Can't remember exactly what he said but something along the lines of they just burn through cash, all hype etc.
Some good news and an update on Cimetra progress in USA, India and Eastern Europe would be most welcome. After all the press releases from Roby telling shareholders how much good news was coming our way, he's gone very quiet. Makes me wonder what is happening and whether Roby has fed us all a load of spin. Need something positive please.